AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18568273
Drug: DTaP-IPV//PRP approximately
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP-IPV//PRP approximately T + hepatitis B vaccine
Trial: 16053121
Drug: Breath therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breath therapy
Trial: 7109988
Drug: Remote mental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remote mental healing treatment by healers
Trial: 7109988
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (normal medical treatment)
Trial: 7109988
Drug: Healers' treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healers' treatment
Trial: 27460638
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with anthracyclines
Trial: 27460638
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy without anthracyclines
Trial: 23778382
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day amisulpride plus 800 mg/day sulpiride
Trial: 23778382
Drug: 800 mg/day
RxNorm normalized name: RibaTab 800 mg/day Compliance Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg/day amisulpride
Trial: 17981885
Drug: 0.55 g/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.55 g/kg/day protein diet
Trial: 17981885
Drug: 0.8 g/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 g/kg/day protein diet
Trial: 8729588
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg/day combined with bezafibrate 400 mg/day
Trial: 8729588
Drug: Fluvastatin 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 10 mg combined with cholestyramine 8 g/day
Trial: 8729588
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg combined with cholestyramine 8 g/day
Trial: 8729588
Drug: Fluvastatin 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 10 mg combined with cholestyramine 8 g/day after 8 weeks
Trial: 8729588
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg combined with cholestyramine 8 g/day after 8 weeks
Trial: 8729588
Drug: Niacin monotherapy
RxNorm normalized name: Niacin
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin monotherapy
Trial: 8729588
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg combined with niacin (3 g/day)
Trial: 1678271
Drug: 14 mg
RxNorm normalized name: iodine 0.14 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 mg transdermal patch
Trial: 1678271
Drug: 7 to
RxNorm normalized name: NP-27 Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 to 21 mg transdermal patches
Trial: 1678271
Drug: transdermal patches
RxNorm normalized name: MENTHOL 0.3 g in 100 TOPICAL PATCH [Aroamas Cot Nicotine Transdermal Patches]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: transdermal patches
Trial: 17242633
Drug: Transdermal 17beta‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta‐estradiol at a dose of 50 mug/day and nomegestrol at a dose of 5 mg/day (group B, n = 22)
Trial: 11159619
Drug: Streptococcal spray
RxNorm normalized name: Streptococcal fibrinolysin
DrugBank: Streptokinase (DB00086)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptococcal spray
Trial: 335912
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg orally twice daily for 1 week)
Trial: 335912
Drug: Propranolol and
RxNorm normalized name: propranolol and thiazides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol and Pilocarpine (combined treatment)
Trial: 31410787
Drug: Peficitinib 100
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 100 mg once daily
Trial: 29917064
Drug: Peficitinib 150
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Peficitinib 150 mg once daily
Trial: 17051978
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid solution (A group)
Trial: 17051978
Drug: Electrolyte solution
RxNorm normalized name: electrolyte solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrolyte solution (S group)
Trial: 3435099
Drug: Amantadine 100
RxNorm normalized name: amantadine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 100 mg
Trial: 29303025
Drug: Maternal 25(OH)D
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal 25(OH)D < 75 nmol/L during pregnancy
Trial: 29303025
Drug: Maternal 25(OH)D
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal 25(OH)D ≥ 75 nmol/L during pregnancy
Trial: 24888230
Drug: Ombrabulin 35
RxNorm normalized name: Ombrabulin
DrugBank: Ombrabulin (DB12882)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ombrabulin 35 mg/m²
Trial: 22257576
Drug: Estradiol‐Depot 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol‐Depot 10 mg® (test)
Trial: 28968759
Drug: PENNVAX-G DNA
RxNorm normalized name: Toxoplasma gondii DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PENNVAX-G DNA delivered intramuscularly by Biojector
Trial: 28968759
Drug: PENNVAX-G DNA
RxNorm normalized name: Toxoplasma gondii DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PENNVAX-G DNA delivered intramuscularly by CELLECTRA electroporation device
Trial: 28968759
Drug: PENNVAX-G DNA
RxNorm normalized name: Toxoplasma gondii DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PENNVAX-G DNA followed by MVA-CMDR boost
Trial: 17234439
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid injection
Trial: 7956552
Drug: MOM nutrient
RxNorm normalized name: Votrient
DrugBank: Pazopanib (DB06589)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: MOM nutrient powder (30 g/day)
Trial: 2892349
Drug: Ritanserin, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritanserin, 10 mg b.i.d.
Trial: 31988102
Drug: Linezolid 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 1,200 mg QD
Trial: 31988102
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg BD
Trial: 31988102
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg QD
Trial: 31988102
Drug: Linezolid 300
RxNorm normalized name: linezolid
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linezolid 300 mg BD
Trial: 31988102
Drug: Linezolid 300
RxNorm normalized name: linezolid
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linezolid 300 mg QD
Trial: 31988102
Drug: Linezolid 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 1,200 mg TIW
Trial: 31988102
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of isoniazid, rifampin, pyrazinamide, and ethambutol
Trial: 27903518
Drug: LOW PRO
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LOW PRO diet (0.7 g · kg‐1 · d‐1)
Trial: 27903518
Drug: HIGH PRO
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIGH PRO diet (1.5 g · kg‐1 · d‐1)
Trial: 25612882
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of raw flaxseed powder every day for 40 days
Trial: 7465620
Drug: Fluori‐Methane spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluori‐Methane spray and static passive stretch
Trial: 18201582
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination of telmisartan 40 mg + amlodipine 5 mg (T+A)
Trial: 18201582
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg monotherapy (A)
Trial: 14504682
Drug: Sertraline (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50-200 mg once daily)
Trial: 7840861
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg tropisetron
Trial: 3048759
Drug: Amodiaquine (1800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amodiaquine (1800 mg for 3 days)
Trial: 3048759
Drug: Sulfadoxine-pyrimethamine (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine-pyrimethamine (1500 mg and 75 mg, respectively)
Trial: 31128268
Drug: Citalopram (CTP)
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram (CTP) adjunctive to methylphenidate (MPH)
Trial: 31128268
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) adjunctive to methylphenidate (MPH)
Trial: 28800778
Drug: Individualized PEEP
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized PEEP values determined during a static pulmonary compliance (Cstat)‐directed PEEP titration procedure
Trial: 20835903
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (rejection of ASV treatment or usage <50% of nights possible and/or <4 h/night; n = 59)
Trial: 17157757
Drug: L-carnitine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine supplementation (3000 mg/day)
Trial: 9065092
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine instillations (1 mg, annual scheme)
Trial: 9065092
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (10 patients without bladder cancer and without vaccine instillations)
Trial: 3971650
Drug: Intravenous flecainide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous flecainide (2 mg/kg)
Trial: 23394517
Drug: Flupirtine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupirtine (200 mg p.o.)
Trial: 17197840
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine infusion (1.5 mg/kg bolus at induction, 2 mg/kg/h intraoperatively, 1.33 mg/kg/h for 24 h postoperatively)
Trial: 9727072
Drug: Oral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estrogen (Premarin 1.25 mg)
Trial: 9727072
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen (Estraderm 100TTS)
Trial: 7775623
Drug: Both oral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both oral and transdermal estrogen
Trial: 23280269
Drug: Robotic-assisted home
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robotic-assisted home therapy
Trial: 17021714
Drug: Dipyridamole 400
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole 400 mg/day
Trial: 9291301
Drug: Serotype G1
RxNorm normalized name: Rotavirus serotype G1 Ag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotype G1 monovalent vaccine
Trial: 9291301
Drug: Serotype G1‐G4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotype G1‐G4 tetravalent vaccine
Trial: 3792434
Drug: Ciramadol 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciramadol 15 mg
Trial: 29667496
Drug: INT-SIT (sitting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INT-SIT (sitting interrupted hourly with 20 min light-intensity treadmill desk walking at 1.2-3.5 km/h)
Trial: 27043671
Drug: Olmesartan/amlodipine fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/amlodipine fixed combination 20/5mg
Trial: 24018781
Drug: Olmesartan 20
RxNorm normalized name: olmesartan 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 20 mg
Trial: 22707251
Drug: Nicotine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (4 mg via gum)
Trial: 17852806
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/day for 5 days
Trial: 17852806
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg three times a day for 4 days and a single dose on day 5
Trial: 17852806
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for 4 days and a single dose on day 5 (control for indomethacin)
Trial: 15819388
Drug: Isosorbide-5-mononitrate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (10 mg)
Trial: 15819388
Drug: Bisoprolol fumarate
RxNorm normalized name: Bisoprolol Fumarate
DrugBank: Bisoprolol (DB00612)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Bisoprolol fumarate (5 mg)
Trial: 15819388
Drug: Nisoldipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine (5 mg)
Trial: 8555143
Drug: Implant-retained mandibular
RxNorm normalized name: betaine
DrugBank: Betaine (DB06756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Implant-retained mandibular overdentures and a new maxillary denture
Trial: 2289472
Drug: Clonazepam (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (4.5 mg)
Trial: 31589323
Drug: Lorcaserin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin (10 mg twice daily) plus nicotine patch (21 mg)
Trial: 31589323
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus nicotine patch (21 mg)
Trial: 31765422
Drug: Community based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community based health education provided by community health volunteers (CHVs) with weekly supplements and follow-ups.
Trial: 17419678
Drug: EPF treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPF treatment (60 mg Icariin, 15 mg Daidzein, and 3 mg Genistein daily)
Trial: 20336635
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy (ET)
Trial: 10365355
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 2 mg 4 mL-1, 12 hourly (maximum four doses)
Trial: 10365355
Drug: Placebo, 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 12 hourly (maximum four doses)
Trial: 2285296
Drug: Intravenous chloramphenicol
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous chloramphenicol succinate
Trial: 2285296
Drug: Oral chloramphenicol
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral chloramphenicol capsules
Trial: 7033352
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g, four times daily)
Trial: 27798022
Drug: Parenting Acceptance
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenting Acceptance and Commitment Therapy (PACT)
Trial: 31479745
Drug: Cardiac Resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac Resynchronization Therapy Defibrillator (CRT‐D) implantation
Trial: 21792642
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) - low exposure (<1,500 mg average daily dose)
Trial: 21792642
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) - high exposure (≥1,500 mg average daily dose)
Trial: 21792642
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) - any exposure (<1,500 or ≥1,500 average daily dose)
Trial: 24122181
Drug: Quinacrine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinacrine (300 mg daily)
Trial: 19278902
Drug: Deferred treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred treatment (random assignment)
Trial: 17140572
Drug: P and
RxNorm normalized name: P and S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P and 4 mg E(2) orally (n = 54)
Trial: 9690055
Drug: Intensive subcutaneous
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive subcutaneous insulin therapy for about 12 days in a subgroup of 7 diabetic subjects
Trial: 30973970
Drug: Oral navoximod
RxNorm normalized name: Navoximod
DrugBank: Navoximod (DB15439)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral navoximod (200 mg tablet)
Trial: 30973970
Drug: Intravenous navoximod
RxNorm normalized name: Navoximod
DrugBank: Navoximod (DB15439)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous navoximod (5 mg solution)
Trial: 30973970
Drug: [14C]‐navoximod (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [14C]‐navoximod (200 mg/600 μCi) as an oral solution
Trial: 30973970
Drug: Navoximod (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Navoximod (200 mg)
Trial: 12914803
Drug: Individual cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive therapy
Trial: 24281563
Drug: Group cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive behavioural therapy (CBTG)
Trial: 17324239
Drug: Transdermal GTN
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal GTN (0.6 mg h(‐1) for 2 h, administered 24 h before IR)
Trial: 17324239
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (2 g i.v. at the time of GTN administration) + GTN
Trial: 17324239
Drug: Ciclosporin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclosporin (100 mg 2 h prior to GTN administration) + GTN
Trial: 14735403
Drug: Staphylococcal vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Staphylococcal vaccine (Staphypan Berna)
Trial: 11680551
Drug: Age, gender,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Age, gender, gender match, experience with cognitive-behavioral therapy (CBT)
Trial: 9137231
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of omega-3 fatty acids daily
Trial: 2444961
Drug: Verapamil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil infusion at 5 mg/h
Trial: 2444961
Drug: Elemental calcium
RxNorm normalized name: Elemental calcium
DrugBank: Calcium (DB01373)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemental calcium infusion at 3 mg/kg over 10 minutes
Trial: 29397432
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy (18 days of standardised treatment combining thermal therapy and supervised mobilisation in a thermal pool)
Trial: 29397432
Drug: Control (spa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (spa therapy delayed for 6 months)
Trial: 23591294
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) 6 mg · kg(‐1)
Trial: 15845797
Drug: 0.3 mmol/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mmol/kg gadolinium dose
Trial: 15845797
Drug: 0.4 mmol/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mmol/kg gadolinium dose
Trial: 10229291
Drug: Lipid lowering
RxNorm normalized name: Lipid lowering agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid lowering therapy according to SMAC guidelines
Trial: 8671425
Drug: HP-FSH (highly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HP-FSH (highly purified follicle stimulating hormone)
Trial: 31409394
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PD-1 and CTLA-4 inhibition, tumor-directed radiation, cyclophosphamide (CTX), and L-n6-(1-iminoethyl)-lysine (L-NIL)
Trial: 31409394
Drug: PD-1 and
RxNorm normalized name: Recombinant pd-1 mab cs1003
DrugBank: Nofazinlimab (DB18852)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PD-1 and CTLA-4 blockade, and radiotherapy alone or in combination
Trial: 31409394
Drug: CTX/L-NIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CTX/L-NIL
Trial: 29482797
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of auricular and systemic acupuncture (GIII)